Product Name: PRAMIRACETAM SULFATE
Synonyms: PRAMIRACETAM SULFATE;Pramiracetam sulphate;Amacetam sulfate;CI-879;N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide sulfate;1-PyrrolidineacetaMide, N-(2-(bis(1-Methylethyl)aMino)ethyl)-2-oxo-;N-(2-(Diisopropylamino)ethyl)-2-(2-oxopyrrolidin-1-yl)acetamide sulfate;N-[2-(Diisopropylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide
CAS: 72869-16-0
MF: C14H27N3O2.H2O4S
MW: 367.464
EINECS:
Product Categories: Health supplements;APIS;Brain health drug;Nootropic
Mol File: 72869-16-0.mol
PRAMIRACETAM SULFATE Structure
PRAMIRACETAM SULFATE Chemical Properties
Safety Information
Toxicity LD50 in male, female mice (mg/kg): 5434, 4355 orally (Poschel)
MSDS Information
PRAMIRACETAM SULFATE Usage And Synthesis
Description Pramiracetam sulfate, together with aniracetam are two nootropics of the piracetam family introduced in 1993 for the treatment of attention and memory disorders resulting from degenerative or vascular disorders in the elderly. In patients with mild to moderate primary degenerative dementia, treatment with 75-300 mg/day of pramiracetam reduced depression,anxiety, sleep disturbance, and hostility with no observable adverse reactions. Significant improvement of performance on measures of memory, especially delayed recall, have been observed for pramiracetam treated patients with brain injury.
Originator Warner-Lambert (U.S.A.)
Uses Cognition adjuvant.
Brand name Remen; Neupramir; Prarnistar